EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations

Ting Zhang, Yang Han, Weijuan Huang, Hejiang Wei, Yingze Zhao, Liumei Shu, Yaxin Guo, Beiwei Ye, Jianfang Zhou, Jun Liu iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ting Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Co-constructed by the Province and Minis…. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Influenza Vaccines, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Excellent Young Scientist Program of the National Natural Science Foundation of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As one of the most effective measures to prevent seasonal influenza viruses, annual influenza vaccination is globally recommended. Nevertheless, evidence regarding the impact of repeated vaccination to contemporary and future influenza has been inconclusive. A total of 100 subjects singly or repeatedly immunized with influenza vaccines including 3C.2a1 or 3C.3a1 A(H3N2) during 2018–2019 and 2019–2020 influenza season were recruited. We investigated neutralization antibody by microneutralization assay using four antigenically distinct A(H3N2) viruses circulating from 2018 to 2023, and tracked the dynamics of B cell receptor (BCR) repertoire for consecutive vaccinations. We found that vaccination elicited cross‐reactive antibody responses against future emerging strains. Broader neutralizing antibodies to A(H3N2) viruses and more diverse BCR repertoires were observed in the repeated vaccination. Meanwhile, a higher frequency of BCR sequences shared among the repeated‐vaccinated individuals with consistently boosting antibody response was found than those with a reduced antibody response. Our findings suggest that repeated seasonal vaccination could broaden the breadth of antibody responses, which may improve vaccine protection against future emerging viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H3N2 SubtypeInfluenza VaccinesAntibodies, NeutralizingAntibodies, ViralInfluenza, HumanCross ReactionsHumansAdultMaleFemaleVaccinationMiddle AgedYoung AdultNeutralization TestsReceptors, Antigen, B-CellAdolescent

Stichwörter der Autor:innen

B antigenic sitesB cell receptor repertoireneutralizing antibodyrepeated vaccination

Substanzen

Influenza VaccinesAntibodies, NeutralizingAntibodies, ViralReceptors, Antigen, B-Cell

Autor:innen und Institutionen

  • Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China.
  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing,…
  • NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Research Unit of Adaptive Evolution and Control of Emerging Viruses (2018RU009), Chinese Academy of Medical Sciences, Beijing, China.
  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Jun Liu

Förderung

  • National Key Research and Development Program of China
  • Excellent Young Scientist Program of the National Natural Science Foundation of China
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

Zitieren

APA

Zhang, T., Han, Y., Huang, W., Wei, H., Zhao, Y., Shu, L., Guo, Y., Ye, B., Zhou, J., & Liu, J. (2024). Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations. Journal of Medical Virology. https://doi.org/10.1002/jmv.29743

Vancouver

Zhang T, Han Y, Huang W, Wei H, Zhao Y, Shu L, et al. Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations. Journal of Medical Virology. 2024. doi:10.1002/jmv.29743

BibTeX
@article{Zhang2024,
  author = {Zhang, Ting and Han, Yang and Huang, Weijuan and Wei, Hejiang and Zhao, Yingze and Shu, Liumei and Guo, Yaxin and Ye, Beiwei and Zhou, Jianfang and Liu, Jun},
  title = {Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29743}
}
Kostenlos starten →